TGFB1 and systemic sclerosis: Furthermore, in the present work, we confirm our previous finding that ICs from SLE and PAPS patients elicit a differential modulation of study mediators compared to SSc-ICs [13], without affecting molecules directly involved in fibrogenesis such as TGF-β1.